Response and correction to correspondence on "CTNBB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component"
Language English Country United States Media print-electronic
Document type Letter, Comment
PubMed
34316009
DOI
10.1038/s41379-021-00876-w
PII: S0893-3952(22)00522-1
Knihovny.cz E-resources
- MeSH
- Humans MeSH
- Mutation MeSH
- Thyroid Neoplasms * pathology MeSH
- Thyroid Cancer, Papillary pathology MeSH
- Carcinoma, Papillary * pathology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Letter MeSH
- Comment MeSH
Department of Pathology Faculty of Medicine in Plzen Charles University Czechia Czech Republic
Department of Pathology Rutgers University Hospital New Jersey Medical School Newark NJ USA
Department of Pathology The Medical College of Wisconsin Milwaukee WI USA
See more in PubMed
Roukain A, Sykiotis GP. CTNNB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component. Mod Pathol. 2021. In press.
Suster D, Michal M, Nishino M, Piana S, Bongiovanni M, Blatnik O, et al. Papillary thyroid carcinoma with prominent myofibroblastic stromal component: clinicopathologic, immunohistochemical and next-generation sequencing study of seven cases. Mod Pathol. 2020;33:1702–11. DOI
